NASDAQ: EDSA
Edesa Biotech Inc Stock Ownership - Who owns Edesa Biotech?

Insider buying vs selling

Have Edesa Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Patrick MarshallDirector2025-02-1241,666$1.92
$80.00kBuy
Carlo SistilliDirector2025-02-1210,416$1.92
$20.00kBuy

1 of 1

EDSA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EDSA insiders and whales buy or sell their stock.

EDSA Shareholders

What type of owners hold Edesa Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pardeep Nijhawan84.10%5,905,813$11.34MInsider
Der Velden Peter Van27.78%1,950,862$3.75MInsider
Velan Capital Investment Management LP9.79%687,500$1.32MInstitution
Rubric Capital Management LP9.79%687,500$1.32MInstitution
Stonepine Capital Management LLC9.79%687,500$1.32MInstitution
Nantahala Capital Management LLC8.90%625,000$1.20MInstitution
Herbert S. Chow8.00%561,767$1.08MInsider
Michael J. Brooks3.20%224,870$431.75kInsider
Mary Catherine Brisson2.20%154,680$296.99kInsider
Peter J. Weiler0.93%65,000$124.80kInsider

1 of 3

EDSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EDSA23.71%76.29%Net Buying
RLYB43.46%56.54%
UBX17.66%51.20%Net SellingNet Selling
ABP2.59%53.89%Net BuyingNet Buying
NEUP2.40%97.60%

Edesa Biotech Stock Ownership FAQ

Who owns Edesa Biotech?

Edesa Biotech (NASDAQ: EDSA) is owned by 40.19% institutional shareholders, 129.32% Edesa Biotech insiders, and 0.00% retail investors. Pardeep Nijhawan is the largest individual Edesa Biotech shareholder, owning 5.91M shares representing 84.10% of the company. Pardeep Nijhawan's Edesa Biotech shares are currently valued at $11.34M.

If you're new to stock investing, here's how to buy Edesa Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.